NPI: 1134137375 · BRONX, NY 10454 · Internal Medicine Physician · NPI assigned 08/03/2006
Authorized official KARLIN, MARJI controls 19+ related entities in our dataset. Read more
| Authorized Official | KARLIN, MARJI (CHIEF REVENUE OFFICER) |
| NPI Enumeration Date | 08/03/2006 |
Other providers sharing the same authorized official: KARLIN, MARJI
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,604 | $34K |
| 2019 | 32,062 | $1.14M |
| 2020 | 106,198 | $3.89M |
| 2021 | 157,754 | $5.37M |
| 2022 | 105,344 | $3.80M |
| 2023 | 87,553 | $2.88M |
| 2024 | 91,359 | $2.48M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 43,670 | 34,290 | $3.24M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 19,858 | 15,278 | $1.27M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11,211 | 9,112 | $1.11M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 19,641 | 16,336 | $1.07M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6,831 | 5,976 | $654K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5,367 | 4,958 | $606K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1,422 | 1,402 | $589K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 22,101 | 14,701 | $578K |
| 86480 | 8,828 | 8,655 | $560K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6,138 | 5,157 | $549K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 12,938 | 12,552 | $414K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 9,199 | 9,144 | $373K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4,300 | 2,997 | $311K |
| 97802 | 6,963 | 6,745 | $299K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 15,516 | 15,315 | $298K |
| D0999 | Unspecified diagnostic procedure, by report | 1,809 | 1,701 | $289K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 3,727 | 2,394 | $247K |
| 99443 | 2,708 | 2,656 | $233K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6,036 | 4,259 | $232K |
| 99442 | 3,281 | 3,173 | $231K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 11,286 | 10,064 | $226K |
| 90461 | 4,127 | 4,113 | $218K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1,663 | 1,644 | $211K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1,575 | 1,564 | $198K |
| 99201 | 2,968 | 2,915 | $192K | |
| 99441 | 3,581 | 3,495 | $187K | |
| D9999 | Unspecified adjunctive procedure, by report | 1,267 | 1,003 | $180K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 7,235 | 6,501 | $180K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,445 | 1,432 | $173K |
| 80053 | Comprehensive metabolic panel | 17,612 | 11,956 | $172K |
| 80061 | Lipid panel | 13,607 | 12,705 | $154K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1,769 | 1,754 | $147K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 867 | 861 | $146K |
| 86703 | 9,914 | 8,822 | $139K | |
| 81001 | 28,294 | 9,457 | $124K | |
| 85027 | 21,080 | 20,815 | $119K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 1,372 | 1,350 | $116K |
| 83036 | Hemoglobin; glycosylated (A1C) | 13,795 | 13,500 | $113K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 3,129 | 2,179 | $111K |
| 86769 | 4,183 | 3,154 | $110K | |
| 92558 | 8,149 | 5,733 | $109K | |
| 90677 | 574 | 573 | $104K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 4,931 | 4,902 | $102K |
| 84443 | Thyroid stimulating hormone (TSH) | 6,896 | 6,794 | $96K |
| 86780 | 6,814 | 6,699 | $89K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 3,174 | 3,129 | $86K |
| 11721 | 2,596 | 1,889 | $84K | |
| 90686 | 6,435 | 6,403 | $83K | |
| H0049 | Alcohol and/or drug screening | 1,668 | 1,656 | $81K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 580 | 577 | $80K |
| 87486 | 3,185 | 1,764 | $78K | |
| 0012A | 1,980 | 1,977 | $76K | |
| 36415 | Collection of venous blood by venipuncture | 14,068 | 5,353 | $75K |
| 90746 | 1,218 | 1,213 | $72K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2,493 | 2,473 | $72K |
| 96127 | 11,078 | 10,461 | $70K | |
| 90651 | 1,052 | 1,047 | $69K | |
| 0011A | 2,086 | 2,073 | $66K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 2,071 | 2,066 | $65K |
| 94760 | 8,962 | 4,800 | $64K | |
| 83655 | 4,691 | 4,353 | $62K | |
| 99215 | Prolong outpt/office vis | 351 | 342 | $54K |
| 87581 | 1,452 | 1,432 | $50K | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 2,471 | 2,390 | $49K |
| 0064A | 1,167 | 1,167 | $48K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1,457 | 1,410 | $48K |
| 86803 | 3,372 | 3,347 | $43K | |
| 81025 | 4,475 | 4,154 | $43K | |
| 92551 | 2,445 | 2,065 | $40K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 86 | 85 | $39K |
| 3074F | 12,397 | 9,225 | $38K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 4,698 | 3,427 | $36K |
| 86706 | 3,421 | 3,332 | $35K | |
| 90715 | 1,371 | 1,365 | $35K | |
| 90620 | 735 | 733 | $34K | |
| 99051 | 1,528 | 1,523 | $34K | |
| 87340 | 3,210 | 3,136 | $33K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,358 | 1,574 | $32K |
| 86762 | 2,020 | 1,968 | $29K | |
| 88142 | 1,146 | 1,123 | $26K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 180 | 178 | $25K |
| 99406 | 1,446 | 1,445 | $24K | |
| 86765 | 1,845 | 1,798 | $23K | |
| 71046 | Radiologic examination, chest; 2 views | 651 | 646 | $23K |
| 99381 | 208 | 206 | $23K | |
| 86787 | 2,013 | 1,962 | $23K | |
| 97803 | 400 | 395 | $22K | |
| 92250 | 496 | 486 | $21K | |
| 86735 | 1,831 | 1,786 | $21K | |
| 82728 | 1,595 | 1,578 | $21K | |
| 82948 | 2,042 | 1,095 | $20K | |
| 99173 | 4,052 | 4,027 | $20K | |
| 99383 | 161 | 161 | $19K | |
| 92015 | Determination of refractive state | 724 | 722 | $18K |
| 99385 | 119 | 118 | $16K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 776 | 577 | $16K |
| 80076 | 1,954 | 1,942 | $16K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,053 | 1,939 | $16K |
| 87800 | 422 | 395 | $16K | |
| 83550 | 2,001 | 1,964 | $15K | |
| 90732 | 118 | 117 | $14K | |
| 90674 | 613 | 605 | $14K | |
| 81408 | 14 | 14 | $13K | |
| 83540 | 2,150 | 2,111 | $13K | |
| 90714 | 524 | 522 | $12K | |
| 76801 | 87 | 82 | $11K | |
| 84702 | 785 | 701 | $11K | |
| D0120 | Periodic oral evaluation - established patient | 1,251 | 800 | $10K |
| 84439 | 1,136 | 1,111 | $10K | |
| D0150 | Comprehensive oral evaluation - new or established patient | 1,032 | 528 | $9K |
| 90670 | 815 | 810 | $9K | |
| 0134A | 209 | 209 | $9K | |
| 87081 | 1,299 | 1,259 | $9K | |
| 99384 | 67 | 67 | $9K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 312 | 312 | $9K |
| 90480 | 187 | 187 | $8K | |
| 90707 | 201 | 200 | $7K | |
| 83020 | 519 | 488 | $7K | |
| D0274 | Bitewings - four radiographic images | 875 | 833 | $6K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 116 | 75 | $6K |
| 85045 | 1,534 | 1,520 | $6K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 44 | 43 | $6K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 121 | 121 | $6K |
| 96161 | 886 | 813 | $6K | |
| 90656 | 513 | 513 | $6K | |
| 91322 | 86 | 85 | $6K | |
| 86708 | 462 | 461 | $6K | |
| 82043 | 1,090 | 1,081 | $6K | |
| 86580 | 414 | 355 | $5K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 329 | 320 | $5K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 42 | 40 | $5K |
| G0467 | Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 1,635 | 1,441 | $5K |
| 82607 | 326 | 321 | $5K | |
| D0220 | Intraoral - periapical first radiographic image | 1,235 | 1,211 | $4K |
| 90697 | 33 | 33 | $4K | |
| 86850 | 295 | 271 | $4K | |
| 90734 | 579 | 578 | $4K | |
| D4341 | 239 | 103 | $4K | |
| 90716 | 103 | 103 | $4K | |
| D1110 | Prophylaxis - adult | 406 | 397 | $4K |
| 0072A | 78 | 78 | $4K | |
| 0071A | 77 | 77 | $4K | |
| 90633 | 479 | 479 | $3K | |
| D0140 | Limited oral evaluation - problem focused | 320 | 308 | $3K |
| 0124A | 56 | 56 | $3K | |
| 86592 | 493 | 480 | $3K | |
| 99382 | 266 | 146 | $3K | |
| 81161 | 14 | 14 | $3K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 532 | 496 | $2K |
| D1208 | Topical application of fluoride, excluding varnish | 701 | 696 | $2K |
| 84460 | 451 | 446 | $2K | |
| D1120 | Prophylaxis - child | 238 | 231 | $2K |
| 86901 | 342 | 314 | $2K | |
| 90662 | 102 | 101 | $2K | |
| 90698 | 295 | 294 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 267 | 265 | $2K |
| 81003 | 885 | 864 | $2K | |
| 82248 | 384 | 383 | $2K | |
| 86900 | 338 | 310 | $2K | |
| D0230 | Intraoral - periapical each additional radiographic image | 823 | 820 | $2K |
| 86003 | 75 | 74 | $2K | |
| 84450 | 433 | 429 | $2K | |
| D0191 | 315 | 219 | $2K | |
| D7140 | Extraction, erupted tooth or exposed root | 27 | 27 | $2K |
| 81405 | 12 | 12 | $2K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 12 | 12 | $2K |
| 82274 | 140 | 140 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 44 | 42 | $2K |
| 90474 | 111 | 111 | $2K | |
| 86704 | 139 | 139 | $2K | |
| D0330 | Panoramic radiographic image | 146 | 146 | $2K |
| 0004A | 31 | 31 | $1K | |
| 11056 | 17 | 17 | $1K | |
| D1330 | 1,053 | 850 | $1K | |
| 84703 | 251 | 251 | $1K | |
| 90680 | 230 | 227 | $1K | |
| 81361 | 14 | 14 | $1K | |
| 90473 | 61 | 61 | $1K | |
| 90661 | 45 | 45 | $998.26 | |
| 90710 | 64 | 64 | $947.22 | |
| 90672 | 156 | 156 | $922.68 | |
| 81401 | 14 | 14 | $904.20 | |
| 81257 | 15 | 15 | $872.10 | |
| D1351 | Sealant - per tooth | 113 | 37 | $837.48 |
| D1206 | Topical application of fluoride varnish | 105 | 105 | $781.15 |
| 90694 | 27 | 27 | $753.19 | |
| 90653 | 41 | 41 | $751.17 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 12 | 12 | $739.63 |
| 72100 | 16 | 16 | $693.10 | |
| 0074A | 15 | 15 | $677.35 | |
| 82785 | 48 | 48 | $653.92 | |
| 81243 | 14 | 14 | $593.19 | |
| 81255 | 14 | 14 | $535.11 | |
| 82947 | 126 | 124 | $492.93 | |
| 81200 | 14 | 14 | $491.43 | |
| 81251 | 14 | 14 | $491.43 | |
| 82951 | 43 | 38 | $427.59 | |
| 81400 | 14 | 14 | $422.16 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 758 | 726 | $420.31 |
| 81260 | 14 | 14 | $408.82 | |
| 83525 | 34 | 33 | $396.54 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 32 | 31 | $375.53 |
| 82746 | 27 | 27 | $373.62 | |
| 90744 | 43 | 43 | $368.91 | |
| 87177 | 36 | 30 | $341.49 | |
| 82105 | 24 | 24 | $310.30 | |
| 90696 | 50 | 50 | $284.30 | |
| 86593 | 61 | 61 | $282.34 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 14 | 12 | $167.38 |
| D0210 | Intraoral - complete series of radiographic images | 33 | 33 | $151.58 |
| 90648 | 25 | 25 | $143.18 | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 13 | 12 | $135.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 41 | 41 | $123.63 |
| 87186 | 15 | 14 | $118.63 | |
| 87338 | 12 | 12 | $117.33 | |
| 81015 | 24 | 24 | $85.99 | |
| J7510 | Prednisolone oral, per 5 mg | 35 | 34 | $59.50 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 46 | 43 | $29.12 |
| 3077F | 612 | 577 | $0.00 | |
| 3078F | 9,488 | 8,532 | $0.00 | |
| 99499 | 586 | 464 | $0.00 | |
| 1160F | 15 | 13 | $0.00 | |
| 1159F | 21 | 14 | $0.00 | |
| D9230 | Inhalation of nitrous oxide / analgesia, anxiolysis | 12 | 12 | $0.00 |
| 3075F | 1,588 | 1,541 | $0.00 | |
| 3079F | 1,938 | 1,856 | $0.00 | |
| 3080F | 146 | 135 | $0.00 | |
| D1310 | 87 | 87 | $0.00 | |
| 1220F | 988 | 988 | $0.00 | |
| D0602 | 14 | 13 | $0.00 | |
| D0601 | 36 | 34 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 19 | 19 | $0.00 |